H-ILSPFLP^LL-OH

Ref. 3D-PP47402

Produktinformation

• Name: H-ILSPFLP^LL-OH

Beschreibung

Peptide H-ILSPFLP^LL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ILSPFLP^LL-OH include the following: Delivery of toll-like receptor 3 ligand poly (I: C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect Y Du, X Yang, J Li, V Sokolova , S Zou, M Han, H Yan - Acta Biomaterialia, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1742706121000738 Natural killer cells regulate the maturation of liver sinusoidal endothelial cells thereby promoting intrahepatic T-cell responses in a mouse model Y Du, H Yan, S Zou, T Khera , J Li, M Han - Hepatology , 2021 - Wiley Online Libraryhttps://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1676 HBeAg is indispensable for inducing liver sinusoidal endothelial cell activation by hepatitis B virus X Xie, J Luo, D Zhu, W Zhou, X Yang, X Feng - Frontiers in Cellular , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fcimb.2022.797915/full Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses S Roh, YK Lee, BY Ahn, K Kim, A Moon - Virus Research, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168170200002197 Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells S Roh, K Kim - Microbiology and immunology, 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1348-0421.2003.tb03370.x In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma Q Liu, Y Tian, Y Li, W Zhang, W Cai, Y Liu - for immunotherapy of , 2020 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745518/ Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes P Riedl, A Bertoletti , R Lopes, F Lemonnier - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/7/4003/73681 Complementary effects of interleukin-15 and alpha interferon induce immunity in hepatitis B virus transgenic mice M Di Scala, I Otano, I Gil-Fariaca±a, L Vanrell - Journal of , 2016 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01030-16 mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines L He, A Zang, M Du, D Ma, C Yuan, C Zhou, J Mu - Virologica Sinica, 2015 - Springerhttps://link.springer.com/article/10.1007/s12250-015-3606-3 CCR5 deficiency enhances hepatic innate immune cell recruitment and inflammation in a murine model of acute hepatitis B infection KE Stevens, CL Thio , WO Osburn - Immunology and Cell , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imcb.12221 Distinct, Cross-Reactive Epitope Specificities JR Lemonnier, R Schirmbeck - J Immunol, 2006 - academia.eduhttps://www.academia.edu/download/89858970/4003.full.pdf Activation and differentiation of cognate T cells by a dextran-based antigen-presenting system for cancer immunotherapy D Mahata , D Mukherjee , D Biswas - European Journal of , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.202350528 Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice B Wu , Q Zou , Y Hu, B Wang - Human Vaccines & , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/hv.26047 Tolerizing CTL by sustained hepatic PD-L1 expression provides a new therapy approach in mouse sepsis A Von Knethen , A Schafer, L Kuchler, T Knape - Theranostics, 2019 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485280/

• Marke: Biosynth